|
MyGene Pty. Ltd. was a privately held genetic testing services company located in Melbourne, Australia that owned and operated an accredited on-site laboratory. MyGene specialised in the development of genetic tests and interpretive reports that assessed the genetic contribution of personal response to diet, also known as nutrigenetics. ==Founding== MyGene was conceived and established by Harry Banaharis during work done initially in profiling umbilical cord blood and later mesenchymal stem cells. The business value proposition anticipated a desire by individuals to understand their genetic uniqueness and how such knowledge could be put to use to personalise their health choices. After some attempts to secure Australian laboratories to perform the testing in a commercially viable manner he decided to establish his own. In 2006, he funded and deployed a prototype gene testing laboratory within the Alfred Hospital research centre utilising a Biotage Pyrosequencer instrument for analysing epigenetic changes in the promoter of TGF-beta gene to generate data towards his Honours thesis. In 2007 he established the MyGene "DNA to data" commercial laboratory in Melbourne CBD and released the first prototype direct to consumer genetic testing kit, the Sports Performance Gene Test. It analysed single nucleotide polymorphisms (SNPs) in 2 genes known to vary in power versus endurance athletes, ACTN3 and ACE I/D and a gene associated with impact sports head injury APOE4. MyGene Genetic Testing Kit.jpeg|The MyGene Genetic Testing Kit with 2 coded swabs for buccal collection and customer ID card Collection_swabs_and_customer_ID_card_in_the_MyGene_Genetic_Test_Kit.jpeg|Detail of collection swabs and customer ID card MyGene_Sports_Gene_Test_Customer_Brochure.pdf|Mygene Sports Performance Gene Test Brochure In 2009 Harry Banaharis was joined by Nick Argyrou, a property developer and former SelecTV director and his wife Helen Argyrou, a pharmacy entrepreneur. The Argyrou's saw an opportunity to innovate in the crowded meal replacement market and the newly resourced company was oriented towards pursuing the development of nutrigenetic products and services. Graeme Smith, a nutritional biochemist and biomedical researcher was recruited to help formulate the meal replacement variants and develop accompanying genetically prescribed weight loss programs. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Mygene」の詳細全文を読む スポンサード リンク
|